Ascendis Health's anchor investor, private equity firm Coast2Coast, says it is working on measures to shore up liquidity and put an end to its forced sales of the healthcare company's stock. To meet obligations to lenders, Coast2Coast has been a heavy seller of Ascendis shares in recent weeks. The sales, to meet margin calls and to partly settle convertible debt instruments, have contributed to a precipitous share price decline. Ascendis's shares closed at R3.50 on Wednesday, an 83% decline since Coast2Coast paid R20 a share during a rights offer just a year ago.